Yuval Cohen's Net Worth
Yuval Cohen's net worth is estimated to be at least $2,111,482.55 as of 12/22/2024. CoreStreet's estimation of Yuval Cohen's net worth is based on their sale of stock and current holding of stock.
Yuval Cohen is CEO at Corbus Pharmaceuticals Holding. They have executed at least 21 trades of stock as per SEC Form 4 filings. Their most recent trade was for 11,103 units of CRBP stock on 06/17/2024. Their biggest sale was on 06/14/2024 when they sold 29,317 units of Corbus Pharmaceuticals Holding stock for $1,470,833.89. They typically trade 2 times per year.
Total value of insider buys:
- $129,688.60
Total value of insider sells:
- $1,981,793.95
Most recent insider trade:
- June 17, 2024
Yuval Cohen's Insider Trading History
| Corbus Pharmaceuticals Holding | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 17, 2024 | CEO | 11,103 | $46.02 | Sell | $510,960.06 |
June 14, 2024 | CEO | 29,317 | $50.17 | Sell | $1,470,833.89 |
Aug. 10, 2022 | CEO | 3,800 | $0.26 | Buy | $988.00 |
May 16, 2022 | CEO | 10,500 | $0.25 | Buy | $2,625.00 |
March 9, 2022 | CEO | 8,600 | $0.37 | Buy | $3,182.00 |
Nov. 11, 2020 | CEO | 4,240 | $1.21 | Buy | $5,130.40 |
Nov. 11, 2020 | CEO | 4,240 | $1.21 | Buy | $5,130.40 |
Nov. 12, 2019 | CEO | 1,430 | $4.26 | Buy | $6,091.80 |
Aug. 12, 2019 | CEO | 1,175 | $6.06 | Buy | $7,120.50 |
May 13, 2019 | CEO | 995 | $6.99 | Buy | $6,955.05 |
March 14, 2019 | CEO | 1,530 | $6.49 | Buy | $9,929.70 |
May 15, 2018 | CEO | 1,725 | $5.85 | Buy | $10,091.25 |
March 14, 2018 | CEO | 1,160 | $6.89 | Buy | $7,992.40 |
Nov. 10, 2017 | CEO | 1,000 | $7.17 | Buy | $7,170.00 |
Aug. 11, 2017 | CEO | 1,695 | $6.00 | Buy | $10,170.00 |
May 11, 2017 | CEO | 3,250 | $6.01 | Buy | $19,532.50 |
Nov. 22, 2016 | CEO | 1,340 | $7.64 | Buy | $10,237.60 |
June 6, 2016 | CEO | 1,500 | $3.34 | Buy | $5,010.00 |
May 18, 2016 | CEO | 2,125 | $2.40 | Buy | $5,100.00 |
Aug. 17, 2015 | CEO | 2,100 | $1.92 | Buy | $4,032.00 |
Dec. 3, 2014 | CEO | 1,000 | $3.20 | Buy | $3,200.00 |